Living Cell Technologies Ltd at Vertical Events Gold Coast Investment Showcase Transcript
Thank you, Chrissy. Thank you for such a lovely introduction.
Yes, my name is Belinda Di Bartolo. A little bit of background about me. I have about 20 years' experience in academic research and recently joined LCT in January this year to drive forward this exciting groundbreaking research in NTCELL. So that's what I'm going to take you through today.
That's our disclaimer. So Living Cell Technologies is an Australasian biotechnology company whose mission is to discover, develop, and commercialize novel treatments for debilitating conditions. And we do this by leveraging the potential of living cells and using these living cells to address the unmet need in these serious conditions.
And so, as a company, we've previously worked in the diabetes field and developed a product called DIABECELL. And this was acquired and is now being further developed by Otsuka Pharmaceutical Factory in the US. And so, we are now focused in the area of Parkinson's disease. And I'm going to tell you today about NTCELL.
So this our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |